← European Medicine Shortage Tracker
Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.
0 medicines currently affected according to AIFA (Italy) · updated 14 September 2026
0 product-level reports are open, 0 of them newly filed in September 2026.
How to read this register: AIFA's carenze lists are grouped by mitigation: equivalents available, alternative treatment available, or import authorisation possible — the alternatives column reflects that.
Marketing-authorisation holders must notify AIFA well ahead of a foreseeable supply interruption; AIFA publishes the resulting carenze lists — the largest register in this tracker — split by remedy rather than lumped together.
For shortages without an Italian equivalent, AIFA can authorise importing a foreign version of the same medicine, and it can block exports of medicines in shortage to keep stock in the country.
Italian pharmacies routinely dispense same-substance equivalents under the national substitution framework, so an entry on the equivalents list usually means inconvenience rather than interruption of treatment.
Hospital-channel medicines run through regional procurement, where shortages are managed by tender substitution — the reason some hospital products appear here long before patients notice.
AIFA's lists are organised by remedy: equivalents available, an alternative treatment available, or import authorisation possible. If your medicine sits on the import list, your doctor or pharmacy can pursue AIFA's authorisation to source a foreign equivalent; otherwise your farmacia can identify same-substance equivalents. Never stop a treatment on your own — confirm any switch with your pharmacist or prescriber.
Searched locally as: carenza di farmaci, farmaco introvabile, farmaci carenti.
| Medicine | Status | Reported | Expected end |
|---|
| Medicine | Status | Since | Expected end | Reports |
|---|
As of 14 September 2026, 0 medicines have open availability reports in AIFA (Italy), covering 0 product-level entries. 0 new reports were filed in September 2026.
AIFA (Italy) — this page aggregates it daily and links every entry back to the official record. AIFA's carenze lists are grouped by mitigation: equivalents available, alternative treatment available, or import authorisation possible — the alternatives column reflects that.
Check which AIFA list it sits on (linked from every row here): if equivalents exist your pharmacist can dispense one; if it is on the import list, your doctor or pharmacy can obtain AIFA's authorisation for a foreign pack; if an alternative treatment is indicated, that is a prescriber decision. Never piece together a solution from online sellers.
Partly counting method: AIFA lists every affected presentation, including hospital products and long-running cases with working mitigations. The underlying causes reported to AIFA are dominated by production problems and commercial withdrawals, layered over the same global API concentration that affects all of Europe.
Newsrooms and health sites may embed the live Italy shortage count — free, with attribution:
<iframe src="https://www.mobidoctor.eu/medicine-shortages/country/it/embed.html" width="100%" height="130" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Medicine shortages in Italy"></iframe> <p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/country/it/">Medicine shortages in Italy — European Medicine Shortage Tracker</a> by MobiDoctor</p>